Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 22, 2022
Accession Number: 0001140361-22-029967
Submission Type: POS AM
CIK: 0001595893
Company Name: Turning Point Therapeutics, Inc.
File Number: 333-238300

Turning Point Therapeutics is now a
Bristol Myers Squibb company

Select OK for information about Turning Point Therapeutics.

Select BMS to learn more about Bristol Myers Squibb